CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model-Reference-Cited by-同舟云学术

CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model

Published:2020-05-16 Issue:6 Volume:85 Page:1177-1182
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Azambuja J. H.^ORCID,Schuh R. S.,Michels L. R.,Gelsleichter N. E.,Beckenkamp L. R.,Lenz G. S.,de Oliveira F. H.,Wink M. R.,Stefani M. A.,Battastini A. M. O.,Teixeira H. F.,Braganhol E.

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-020-04077-1.pdf

Reference14 articles.

1. Ostrom QT, Bauchet L, Davis FG et al (2014) The epidemiology of glioma in adults: a "state of the science" review. Neuro Oncol 16:896–913. https://doi.org/10.1093/neuonc/nou087

2. Chua J, Nafziger E, Leung D (2019) Evidence-based practice: temozolomide beyond glioblastoma. Curr Oncol Rep 21:1–9. https://doi.org/10.1007/s11912-019-0783-5

3. Stupp R, van den Bent MJ, Hegi ME (2005) Optimal role of temozolomide in the treatment of malignant gliomas. Curr Neurol Neurosci Rep 5:198–206

4. Wijaya J, Fukuda Y, Schuetz JD (2017) Obstacles to brain tumor therapy: key ABC transporters. Int J Mol Sci. https://doi.org/10.3390/ijms18122544

5. Azambuja JH, Gelsleichter NE, Beckenkamp LR et al (2018) CD73 downregulation decreases In vitro and In vivo glioblastoma growth. Mol Neurobiol. https://doi.org/10.1007/s12035-018-1240-4

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Purinergic system in cancer stem cells;Purinergic Signalling;2023-11-15

2. Effects of abnormal expression of CD73 on malignant phenotype of nasopharyngeal carcinoma;Journal of Molecular Histology;2023-10-24

3. Combination drug loaded lipid-based nanocarriers as treatment entity for battling glioblastoma multiforme;Journal of Drug Delivery Science and Technology;2023-09

4. ENTPD1 (CD39) and NT5E (CD73) expression in human glioblastoma: an in silico analysis;Purinergic Signalling;2023-07-04

5. Purinergic approach to effective glioma treatment with temozolomide reveals enhanced anti-cancer effects mediated by P2X7 receptor;Cellular Signalling;2023-06